logofg

ACTUALITE

How White Coat Hypertension Impacts Pregnancy

White coat hypertension during pregnancy may increase the risk of complications for the mother and her baby.

placeholder image

A recent study published in the U.S. journal Hypertension on May 28, 2020, the International Day of Action for Women’s Health, evaluated the effects of white coat hypertension on mothers and babies during pregnancy. White coat hypertension is defined as elevated blood pressure (BP) when measured by a doctor of midwife at an appointment (BP ≥140/90 mm Hg) with normal BP when checked at home with a blood pressure monitor.
The authors conducted a meta-analysis study on 20 clinical studies. They observed that women with white coat hypertension before the twentieth week of pregnancy had a higher risk of vascular and renal (kidney) complications compared to those with normal blood pressure at all times. These women were also more at risk of high blood pressure continuing postpartum.
White coat hypertension also exposed the baby to an elevated risk of premature birth, low birth weight and perinatal complications. This means that white coat hypertension during a woman’s first two trimesters of pregnancy is a new marker of a pregnancy with greater risk of complications, justifying closer monitoring of the mother and her baby all throughout pregnancy. These moms should also have their blood pressure re-evaluated postpartum. Maternal and Perinatal Outcomes of White Coat Hypertension During Pregnancy.
A Systematic Review and Meta-Analysis.
https://doi.org/10.1161/HYPERTENSIONAHA.119.14627 Hypertension. 2020;(76):157-166.

 

SEE ALSO

placeholder

Are medications sexist?

Erving Zucker and his colleagues at University of California Berkeley conducted research in more than 5,000 publications and focused on 86 medications on the U.S. market administered to men and women. At equivalent doses, 76 of them had a higher concentration in women’s blood than in men’s blood, [...]

READ MORE

placeholder

Alert, Anticipate, Act to Save Lives

In France, 200 women die every day from cardiovascular disease in all its forms, and 25,000 die every day worldwide, with delays in treatment mainly due to a lack of awareness. The causes of death in France are well documented: women die most often from a stroke, then from heart attack or heart [...]

READ MORE

placeholder

Prof. Claire Mounier-Vehier Included in LinkedIn Top Voices 2020

LinkedIn unveiled its Top Voices list in November 2020. It featured the 25 most prominent contributors in 2020 in France on the largest professional network in the world and included Valérie Pécresse, Anne Hidalgo, Bruno Le Maire, Julia De Funès, Nicolas Dufourcq (CEO of BPI France), and Olivier [...]

READ MORE

 Your gift improves
prevention for women at key moments in their lives